超声引导射频消融与手术治疗低风险甲状腺微小乳头状癌:超过5年随访结果
研究纳入2013年1月至11月中国某教学医院的174例孤立性甲状腺内PTMC患者,94例选择射频消融,80例选择手术。5年随访显示两组肿瘤学结局相似,手术组耗时更长、住院更久、费用更高,且出现2例永久性喉返神经损伤和1例永久性甲状旁腺功能减退,而射频消融组无并发症;手术组甲状腺相关生活质量较低。作者认为对精心选择的低风险甲状腺内PTMC,射频消融的肿瘤学效果不劣于开放手术,且生活质量更高、总费用更低。
要点
- 174例孤立性甲状腺内PTMC患者中,94例接受射频消融,80例接受手术。
- 5年随访两组肿瘤学结局相似。
- 手术组耗时更长、住院更久、费用更高(均p < 0.001),且生活质量较低。
核心结论
- 对精心选择的低风险甲状腺内PTMC,射频消融的肿瘤学效果不劣于开放手术,且与更高的生活质量和更低的总体费用相关。
研究设计与样本
- 2013年1月至2013年11月在中国某教学医院识别174例孤立性甲状腺内PTMC连续患者,排除更具侵袭性或晚期PTMC者。
- 94例选择射频消融,80例选择手术;射频消融组经粗针活检证实为PTMC且无侵袭性组织学类型,手术组经最终手术病理证实。
- 手术范围由患者偏好与外科医生协商决定:58例(72.5%)行肺叶切除,22例(27.5%)行全甲状腺切除,53例(66.3%)行淋巴结清扫。
主要发现
- 两组患者特异性变量相似,5年随访后肿瘤学结局也相似。
- 与射频消融相比,手术耗时更长、住院时间更长且费用更高(均p < 0.001)。
- 手术组发生3例并发症:2例(2.5%)永久性喉返神经损伤和1例(1.3%)永久性甲状旁腺功能减退,射频消融组无并发症报告(p = 0.095)。
- 手术组治疗后甲状腺相关生活质量较低。
临床怎么用
- 作者认为,对于精心选择的低风险甲状腺内PTMC,射频消融的肿瘤学效果不劣于开放手术,且与更高的生活质量和更低的总体费用相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Papillary thyroid microcarcinoma (PTMC) typically carries an excellent prognosis regardless of the treatment option pursued. Radiofrequency ablation (RFA) for thyroid disease has been utilized for benign lesions and in patients who are poor surgical candidates for thyroid cancers with compression symptoms, but the efficacy and limitations of RFA as first-line therapy for PTMC has not been described in adequate detail. The purpose of our study was to investigate RFA versus thyroidectomy in terms of efficacy, oncologic outcomes, quality of life, complications, and costs over a 5-year period of follow-up. Methods: From January 2013 to November 2013, 174 consecutive patients with an isolated, solitary intrathyroidal PTMC were identified in a Chinese teaching hospital. Those with more aggressive or advanced PTMCs were not included. Ninety-four patients elected RFA and 80 patients elected surgery for treatment of these PTMC. Nodules were confirmed to be PTMC without an aggressive histological type by core needle biopsy in the RFA group and by final surgical pathology in the surgery group. The extent of surgery was decided based on patient preferences in consultation with the surgeons. Of all the patients, 58 (72.5%) underwent lobectomy, 22 (27.5%) underwent total thyroidectomy, and 53 (66.3%) underwent lymph node dissection. Pre- and post-treatment variables were compared between the two groups, including demographics, tumor characteristics, treatment, local tumor progression, lymph node metastasis, distant metastasis, local recurrence, complications, and quality-of-life findings. Results: Patient-specific variables were similar between groups, as were oncologic outcomes after 5 years of follow-up. When compared with RFA, surgery took longer, had a longer hospitalization time, and was costlier (all p < 0.001). The surgery group had three complications, with 2 (2.5%) permanent recurrent laryngeal nerve injuries and 1 (1.3%) case of permanent hypoparathyroidism, while none was reported in the RFA group (p = 0.095). The surgery group had a lower post-treatment thyroid-related quality of life. Conclusions: For carefully selected low-risk intrathyroidal PTMC, RFA was not oncologically inferior to open surgery, and it was associated with a higher quality of life and lower overall costs.
引用
- Zhang M, Tufano RP, Russell JO, et al. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up. Thyroid. 2020. PMID: 31910107. doi:10.1089/thy.2019.0147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。